drugset / Trial / NCT05160350
Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a randomized, double-blind parallel group placebo-controlled clinical trial with the aim of investigating the effect of probiotic versus placebo on drug-resistant adult patients with epilepsy.
Timeline
- Start
- 2021-04-21
- Primary completion
- 2021-10-23
- Completion
- 2021-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VSL#3 | Other / unclassified | — | — |